ABCL
AbCellera Biologics, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website abcellera.com
- Employees(FY) 630
- ISIN CA00288U1066
Performance
-7.85%
1W
-10.12%
1M
-31.84%
3M
-16.89%
6M
-36.25%
YTD
-37.67%
1Y
Profile
AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune responses, which are pre-enriched for antibodies. The company had discovery programs that are either completed, in progress, or under contract with partners. It has a research collaboration and license agreement with Eli Lilly and Company; and a research collaboration with Confo Therapeutics for the discovery of therapeutic antibody candidates targeting two undisclosed GPCR targets. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.
Investment Analysis Report: ABCL
Overview
ABCL is a company operating in the Health Technology sector, specifically in the Biotechnology industry. The company has a market capitalization of $1.55 billion. In this report, we will conduct a comprehensive analysis of ABCL's financial statements over the past three years, focusing on the Balance She...
Technical Analysis of ABCL 2024-05-10
Overview:
In analyzing the technical indicators for ABCL stock over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions to guide in...
Recent News & Updates
- 2024-02-29 06:27
- 2024-02-26 06:55
3 Highly Rated Biotech Stocks to Buy for 300% Gains(InvestorPlace)
- 2024-02-23 16:30
AbCellera Announces Resignation of Board Member(Business Wire)
- 2024-02-23 03:30
AbCellera Announces Resignation of Board Member(Businesswire)
- 2024-02-22 20:15
- 2024-02-22 07:15
- 2024-02-21 09:22
- 2024-02-21 07:09
Q4 2023 Abcellera Biologics Inc Earnings Call(Thomson Reuters StreetEvents)
- 2024-02-20 23:00
- 2024-02-20 19:00
- 2024-02-20 16:57
- 2024-02-20 16:05
AbCellera Reports Full Year 2023 Business Results(Business Wire)
- 2024-02-20 06:00
- 2024-02-20 03:05
AbCellera Reports Full Year 2023 Business Results(Businesswire)
- 2024-02-01 07:40
- 2024-01-30 13:02
Baillie Gifford Adjusts Stake in AbCellera Biologics Inc(GuruFocus.com)
- 2024-01-23 16:05
- 2024-01-23 03:05
- 2024-01-15 09:30
3 Growth Stocks That Could Go Parabolic in 2024(Motley Fool)
- 2024-01-03 09:40
- 2023-12-20 16:05
- 2023-12-20 03:05
- 2023-12-16 13:00
AI Meets Biotech: 3 Top Stocks Transforming Medical Science(InvestorPlace)
- 2023-12-11 15:30
16 Best Penny Stocks To Buy For 2024(Insider Monkey)
- 2023-11-24 09:03
- 2023-11-16 16:05
- 2023-11-16 03:05
- 2023-11-03 12:05
- 2023-11-03 10:51
- 2023-11-03 08:42
Q3 2023 Abcellera Biologics Inc Earnings Call(Thomson Reuters StreetEvents)